NICE Recommends Tecfidera for Multiple Sclerosis

Drug Industry Daily
A A
Biogen Idec said it will launch its multiple sclerosis drug Tecfidera within three months in England and Wales following a final coverage recommendation this week from the UK healthcare pricing watchdog.

To View This Article:

Login

Subscribe To Drug Industry Daily